Recent developments in human immunodeficiency virus-1 latency research

Journal of General Virology

Volumn 94, Issue PART 5, 2013, Pages 917-932

  Chan, Chi Ngai ^a   Dietrich, Isabelle ^a   Hosie, Margaret J ^a   Willett, Brian J ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIRAM; MARAVIROC; VALPROIC ACID; VORINOSTAT;

CD4+ T LYMPHOCYTE; CLINICAL TRIAL; DRUG PENETRATION; GENE EXPRESSION; GENE THERAPY; HEMATOPOIETIC STEM CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA; VIREMIA; VIRUS LATENCY; VIRUS REACTIVATION;

EID: 84876400094     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.049296-0     Document Type: Review

References (234)

1. Ackley, C. D., Yamamoto, J. K., Levy, N., Pedersen, N. C. & Cooper, M. D. (1990). Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol 64, 5652-5655.
2. Alexaki, A. & Wigdahl, B. (2008). HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog 4, e1000215.
3. Allers, K., HUtter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E. & Schneider, T. (2011). Evidence for the cure of HIV infection by CCR5A32/A32 stem cell transplantation. Blood 117, 2791-2799.
4. Anderson, J., Li, M.-J., Palmer, B., Remling, L., Li, S., Yam, P., Yee, J.-K., Rossi, J., Zaia, J. & Akkina, R. (2007). Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cells. Mol Ther 15, 1182-1188.
5. Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D. & Margolis, D. M. (2009). Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 25, 207-212.
6. Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F. (2012). Administration of Vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487, 482-485.
7. Assogba, B. D., Leavell, S., Porter, K. & Burkhard, M. J. (2007). Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency. J Infect Dis 195, 1184-1188.
8. Bai, J., Gorantla, S., Banda, N., Cagnon, L., Rossi, J. & Akkina, R. (2000). Characterization of anti-CCR5 ribozyme-transduced CD34 + hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo. Mol Ther 1, 244-254.
9. Bailey, J. R., Sedaghat, A. R., Kieffer, T., Brennan, T., Lee, P. K., Wind- Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu, Y. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4 + T cells. J Virol 80, 6441-6457.
10. Baldauf, H. M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., Schenkova, K., Ambiel, I., Wabnitz, G. (2012). SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med 18, 1682-1689.
11. Banerjee, C., Archin, N., Michaels, D., Belkina, A. C., Denis, G. V., Bradner, J., Sebastiani, P., Margolis, D. M. & Montano, M. (2012). BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol 92, 1147-1154.
12. Barlough, J. E., Ackley, C. D., George, J. W., Levy, N., Acevedo, R., Moore, P. F., Rideout, B. A., Cooper, M. D. & Pedersen, N. C. (1991). Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immune Defic Syndr 4, 219-227.
13. Beatty, J. A., Willett, B. J., Gault, E. A. & Jarrett, O. (1996). A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol 70, 6199-6206.
14. Bebenek, K., Abbotts, J., Wilson, S. H. & Kunkel, T. A. (1993). Error- prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots. J Biol Chem 268, 10324-10334.
15. Benkirane, M., Chun, R. F., Xiao, H., Ogryzko, V. V., Howard, B. H., Nakatani, Y. & Jeang, K. T. (1998). Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 273, 24898-24905.
16. Berard, M. & Tough, D. F. (2002). Qualitative differences between naïve and memory T cells. Immunology 106, 127-138.
17. Best, B. M., Letendre, S. L., Koopmans, P., Rossi, S. S., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C. M., McArthur, J. C. (2012). Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr 59, 376-381.
18. Biancotto, A., Grivel, J.-C., Gondois-Rey, F., Bettendroffer, L., Vigne, R., Brown, S., Margolis, L. B. & Hirsch, I. (2004). Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. J Virol 78, 10507-10515.
19. Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C. (2009). CpG methylation controls reactivation of HIV from latency. PLoS Pathog 5, e1000554.
20. Bleul, C. C., Wu, L. J., Hoxie, J. A., Springer, T. A. & Mackay, C. R. (1997). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 94, 1925-1930.
21. Boberg, A., Brave, A., Johansson, S., Wahren, B., Hinkula, J. & Rollman, E. (2008). Murine models for HIV vaccination and challenge. Expert Rev Vaccines 7, 117-130.
22. Bosque, A. & Planelles, V. (2009). Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 113, 58-65.
23. Bosque, A., Famiglietti, M., Weyrich, A. S., Goulston, C. & Planelles, V. (2011). Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog 7, e1002288.
24. Brenchley, J. M., Paiardini, M. (2011). Immunodeficiency lentiviral infections in natural and non-natural hosts. Blood 118, 847-854.
25. Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. (2004). CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200, 749-759.
26. Brenchley, J. M., Hill, B. J., Ambrozak, D. R., Price, D. A., Guenaga, J., Casazza, J. P., Kuruppu, J., Yazdani, J., Migueles, S. A. (2004). T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 78, 1160-1168.
27. Brennan, T. P., Woods, J. O., Sedaghat, A. R., Siliciano, J. D., Siliciano, R. F. & Wilke, C. O. (2009). Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4 + T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol 83, 8470-8481.
28. Brooks, D. G., Kitchen, S. G., Kitchen, C. M. R., Scripture-Adams, D. & Zack, J. A. (2001). Generation of HIV latency during thymopoiesis. Nat Med 7, 459-464.
29. Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P. & Stevenson, M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
30. Burke, B., Brown, H. J., Marsden, M. D., Bristol, G., Vatakis, D. N. & Zack, J. A. (2007). Primary cell model for activation-inducible human immunodeficiency virus. J Virol 81, 7424-7434.
31. Burnett, J. C. & Rossi, J. J. (2012). RNA-based therapeutics: current progress and future prospects. Chem Biol 19, 60-71.
32. Burnett, J. C., Lim, K. I., Calafi, A., Rossi, J. J., Schaffer, D. V. & Arkin, A. P. (2010). Combinatorial latency reactivation for HIV-1 subtypes and variants. J Virol 84, 5958-5974.
33. Buzon, M. J., Massanella, M., Llibre, J. M., Esteve, A., Dahl, V., Puertas, M. C., Gatell, J. M., Domingo, P., Paredes, R. (2010). HIV-1 replication and immune dynamics are affected by Raltegravir intensification of HAART-suppressed subjects. Nat Med 16, 460-465.
34. Cabrita, G. J. M., Ferreira, B. S., da Silva, C. L., Gonçalves, R., Almeida-Porada, G. & Cabral, J. M. S. (2003). Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol 21, 233-240.
35. Canestri, A., Lescure, F.-X., Jaureguiberry, S., Moulignier, A., Amiel, A., Marcelin, A. G., Peytavin, G., Tubiana, R., Pialoux, G. & Katlama, (2010). Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 50, 773-778.
36. Carter, C. C., Onafuwa-Nuga, A., McNamara, L. A., Riddell, J., IV, Bixby, D., Savona, M. R. & Collins, K. L. (2010). HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 16, 446-451.
37. Carter, C. C., McNamara, L. A., Onafuwa-Nuga, A., Shackleton, M., Riddell, J., IV, Bixby, D., Savona, M. R., Morrison, S. J. & Collins, K. L. HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells. Cell Host Microbe 9, 223-234.
38. Chahroudi, A., Bosinger, S. E., Vanderford, T. H., Paiardini, M. & Silvestri, G. (2012). Natural SIV hosts: showing AIDS the door. Science 335, 1188-1193.
39. Chan, C. N., McMonagle, E. L., Hosie, M. J. & Willett, B. J. (2013). Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells. Virus Res. 171, 121-128.
40. Chen, L. F., Mu, Y. & Greene, W. C. (2002). Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB. EMBO J 21, 6539-6548.
41. Chiang, K. & Rice, A. P. (2012). MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. Viruses 4, 1390-1409.
42. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. (1996). The beta- chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
43. Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G. (2009). HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15, 893-900.
44. Choudhary, S. K., Rezk, N. L., Ince, W. L., Cheema, M., Zhang, L., Su, L., Swanstrom, R., Kashuba, A. D. & Margolis, D. M. (2009). Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4 + T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-yc-/- mouse. J Virol 83, 8254-8258.
45. Choudhary, S. K., Archin, N. M., Cheema, M., Dahl, N. P., Garcia, J. V. & Margolis, D. M. (2012). Latent HIV-1 infection of resting CD4+ T cells in the humanized Rag2 - /- yc-/- mouse. J Virol 86, 114-120.
46. Chun, T. W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D. & Siliciano, R. F. (1995). In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1, 1284-1290.
47. Chun, T. W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, Hermankova, M., Chadwick, K., Margolick, J. (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188.
48. Chun, T. W., Engel, D., Mizell, S. B., Ehler, L. A. & Fauci, A. S. (1998). Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 188, 83-91.
49. Chun, T. W., Davey, R. T., Jr, Engel, D., Lane, H. C. & Fauci, A. S. (1999). Re-emergence of HIV after stopping therapy. Nature 401, 874-875.
50. Chun, T. W., Nickle, D. C., Justement, J. S., Large, D., Semerjian, A., Curlin, M. E., O'Shea, M. A., Hallahan, C. W., Daucher, M. (2005). HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest 115, 3250-3255.
51. Chun, T.-W., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G., Hallahan, C. W., Kottilil, S., Moir, S., Mican, J. M. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 197, 714-720.
52. Churchill, M. J., Gorry, P. R., Cowley, D., Lal, L., Sonza, S., Purcell, F. J., Thompson, K. A., Gabuzda, D., McArthur, J. C. (2006). Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol 12, 146-152.
53. Cicala, C., Arthos, J., Censoplano, N., Cruz, C., Chung, E., Martinelli, Lempicki, R. A., Natarajan, V., VanRyk, D. (2006). HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T- cells. Virology 345, 105-114.
54. Cillo, A., Krishnan, A., Mitsuyasu, R., McMahon, D., Li, S., Rossi, J., Zaia, J. & Mellors, J. W. (2012). Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for AIDS-related lymphoma. In CROI. Seattle, USA.
55. Coffer, P. J. & Burgering, B. M. (2004). Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4, 889-899.
56. Coiras, M., Lopez-Huertas, M. R., Pérez-Olmeda, M. & Alcami, J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 7, 798-812.
57. Coleman, C. M. & Wu, L. (2009). HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6, 51.
58. Colin, L. & Van Lint, C. (2009). Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6, 111.
59. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S. & Landau, N. R. (1997). Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185, 621-628.
60. Contreras, X., Schweneker, M., Chen, C.-S., McCune, J. M., Deeks, S. G., Martin, J. & Peterlin, B. M. (2009). Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem 284, 6782-6789.
61. Coull, J. J., Romerio, F., Sun, J. M., Volker, J. L., Galvin, K. M., Davie, J. R., Shi, Y., Hansen, U. & Margolis, D. M. (2000). The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 74, 6790-6799.
62. d'Arminio, A., Sabin, C. A., Phillips, A. N., Reiss, P., Weber, R., Kirk, O., El-Sadr, W., De Wit, S., Mateu, S. (2004). Cardio- and cerebrovascular events in HIV-infected persons. AIDS 18, 1811-1817.
63. Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F. & Weiss, R. A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
64. Davey, R. T., Jr, Bhat, N., Yoder, C., Chun, T. W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W. (1999). HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci USA 96, 15109-15114.
65. Davis, B. R., Schwartz, D. H., Marx, J. C., Johnson, C. E., Berry, J. M., Lyding, J., Merigan, T. C. & Zander, A. (1991). Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 65, 1985-1990.
66. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E. (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862.
67. Deeks, S. G. (2011). HIV infection, inflammation, immunosenes- cence, and aging. Annu Rev Med 62, 141-155.
68. Deeks, S. G., Autran, B., Berkhout, B., Benkirane, M., Cairns, S., Chomont, N., Chun, T. W., Churchill, M., Di Mascio, M. (2012). Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 12, 607-614.
69. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
70. Descours, B., Cribier, A., Chable-Bessia, C., Ayinde, D., Rice, G., Crow, Y., Yatim, A., Schwartz, O., Laguette, N. & Benkirane, M. (2012). SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells. Retrovirology 9, 87.
71. Di Mascio, M., Srinivasula, S., Bhattacharjee, A., Cheng, L., Martiniova, L., Herscovitch, P., Lertora, J. & Kiesewetter, D. (2009). Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography. Antimicrob Agents Chemother 53, 4086-4095.
72. Dinoso, J. B., Rabi, S. A., Blankson, J. N., Gama, L., Mankowski, J. L., Siliciano, R. F., Zink, M. C. & Clements, J. E. (2009a). A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 83, 9247-9257.
73. Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A. (2009b). Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci USA 106, 9403-9408.
74. Douek, D. C., Roederer, M. & Koup, R. A. (2009). Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 60, 471-484.
75. Durand, C. M., Ghiaur, G., Siliciano, J. D., Rabi, S. A., Eisele, E. E., Salgado, M., Shan, L., Lai, J. F., Zhang, H. (2012). HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy. J Infect Dis 1014-1018.
76. Egberink, H. F., Keldermans, C. E., Koolen, M. J. & Horzinek, M. C. Humoral immune response to feline immunodeficiency virus in cats with experimentally induced and naturally acquired infections. Am J Vet Res 53, 1133-1138.
77. Eichbaum, Q. (2011). PD-1 signaling in HIV and chronic viral infection-potential for therapeutic intervention? Curr Med Chem 18, 3971-3980.
78. Eisele, E. & Siliciano, R. F. (2012). Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37, 377-388.
79. Else, L. J., Taylor, S., Back, D. J. & Khoo, S. H. (2011). Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir Ther 16, 1149-1167.
80. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
81. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T. (2010). Selective inhibition of BET bromodomains. Nature 468, 1067-1073.
82. Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J. (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300.
83. Flynn, J. N., Dunham, S., Mueller, A., Cannon, C. & Jarrett, O. (2002). Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. Vet Immunol Immunopathol 85, 159-170.
84. Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A. & Fauci, A. S. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238, 800-802.
85. Folks, T. M., Kessler, S. W., Orenstein, J. M., Justement, J. S., Jaffe, S. & Fauci, A. S. (1988). Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242, 919-922.
86. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H. & Fauci, A. S. (1989). Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 86, 2365-2368.
87. Gabriel, R., Lombardo, A., Arens, A., Miller, J. C., Genovese, P., Kaeppel, C., Nowrouzi, A., Bartholomae, C. C., Wang, J. (2011). An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29, 816-823.
88. Gandhi, R. T., Zheng, L., Bosch, R. J., Chan, E. S., Margolis, D. M., Read, S., Kallungal, B., Palmer, S., Medvik, K. The effect of Raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med 7, e1000321.
89. Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C. & Popovic, M. (1986). The role of mononuclear phagocytes in HTLV- III/LAV infection. Science 233, 215-219.
90. Ghose, R., Liou, L. Y., Herrmann, C. H. & Rice, A. P. (2001). Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4+ T lymphocytes by combination of cytokines. J Virol 75, 11336-11343.
91. Goldman, J. P., Blundell, M. P., Lopes, L., Kinnon, C., Di Santo, J. P. & Thrasher, A. J. (1998). Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 103, 335-342.
92. Gonzalez-Scarano, F. & Martin-Garcia, J. (2005). The neuropathogenesis of AIDS. Nat Rev Immunol 5, 69-81.
93. Greger, I. H., Demarchi, F., Giacca, M. & Proudfoot, N. J. (1998). Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res 26, 1294-1301.
94. Gutierrez, C., Diaz, L., Vallejo, A., Hernandez-Novoa, B., Abad, M., Madrid, N., Dahl, V., Rubio, R., Moreno, A. M. (2011). Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected. PLoS ONE 6, e27864.
95. Haaland, R. E., Yu, W. & Rice, A. P. (2005). Identification of LKLF- regulated genes in quiescent CD4 + T lymphocytes. Mol Immunol 42, 627-641.
96. Halfon, P., Giorgetti, C., Khiri, H., Pei naranda, G., Terriou, P., Porcu- Buisson, G. & Chabert-Orsini, V. (2010). Semen may harbor HIV despite effective HAART: another piece in the puzzle. PLoS ONE 5, e10569.
97. Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F. & Siliciano, J. D. (2004). Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol 78, 6122-6133.
98. Han, Y., Wind-Rotolo, M., Yang, H. C., Siliciano, J. D. & Siliciano, R. F. Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 5, 95-106.
99. Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H. C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D. & Siliciano, R. F. (2008). Orientation- dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4, 134-146.
100. Hatano, H., Hayes, T. L., Dahl, V., Sinclair, E., Lee, T. H., Hoh, R., Lampiris, H., Hunt, P. W., Palmer, S. (2011). A randomized, controlled trial of Raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis 203, 960-968.
101. Hecht, R., Stover, J., Bollinger, L., Muhib, F., Case, K. & de Ferranti, D. (2010). Financing of HIV/AIDS programme scale-up in low- income and middle-income countries, 2009-31. Lancet 376, 1254-1260.
102. Hermankova, M., Siliciano, J. D., Zhou, Y., Monie, D., Chadwick, K., Margolick, J. B., Quinn, T. C. & Siliciano, R. F. (2003). Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J Virol 77, 7383-7392.
103. Hesselton, R. M., Greiner, D. L., Mordes, J. P., Rajan, T. V., Sullivan, J. L. & Shultz, L. D. (1995). High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis 172, 974-982.
104. Hirsch, V. M., Fuerst, T. R., Sutter, G., Carroll, M. W., Yang, L. C., Goldstein, S., Piatak, M., Jr, Elkins, W. R., Alvord, W. G. (1996). Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 70, 3741-3752.
105. Hirsch, V. M., Lifson, J. D. & Kuah-Teh, J. (2000). Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. In Advances in Pharmacology, vol. 49, pp. 437-477. Academic Press.
106. Ho, D. D., Rota, T. R. & Hirsch, M. S. (1986). Infection of monocyte/ macrophages by human T lymphotropic virus type III. J Clin Invest 77, 1712-1715.
107. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
108. Holt, N., Wang, J., Kim, K., Friedman, G., Wang, X., Taupin, V., Crooks, M., Kohn, D. B., Gregory, P. D. (2010). Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28, 839-847.
109. Hosie, M. J., Pajek, D., Samman, A. & Willett, B. J. (2011). Feline immunodeficiency virus (FIV) neutralization: a review. Viruses 3, 1870-1890.
110. Howard, K. E., Reckling, S. K., Egan, E. A. & Dean, G. A. (2010). Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology 7, 2.
111. Hutter, G., Nowak, D., Mossner, M., Ganepola, S., Müssig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C. (2009). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360, 692-698.
112. Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Boni, J., Hirschel, B., Weber, R., Trkola, A., Günthard, H. F. & Swiss HIV Cohort Study (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc Natl Acad Sci USA 105, 16725-16730.
113. Jordan, A., Bisgrove, D. & Verdin, E. (2003). HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22, 1868-1877.
114. Josefsson, L., Eriksson, S., Sinclair, E., Ho, T., Killian, M., Epling, L., Shao, W., Lewis, B., Bacchetti, P. (2012). Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 28-34.
115. Joshi, A., Vahlenkamp, T. W., Garg, H., Tompkins, W. A. F. & Tompkins, M. B. (2004). Preferential replication of FIV in activated CD4+CD25+T cells independent of cellular proliferation. Virology 321, 307-322.
116. Joshi, A., Garg, H., Tompkins, M. B. & Tompkins, W. A. (2005). Different thresholds of T cell activation regulate FIV infection of CD4 + CD25 + and CD4 + CD25- cells. Virology 335, 212-221.
117. June, C., Pablo, T., Stein, D., Mitsuyasu, R., Lalezari, J., Wang, S., Lee, & Levine, B., Tang, W. (2012). Induction of acquired CCR5 deficiency with zinc finger nuclease-modified autologous CD4 T cells (SB-728-T) correlates with increases in CD4 count and effects on viral load in HIV-infected subjects. In 19th Conference on Retroviruses and Opportunistic Infections (CROI).
118. Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V. & Verdin, E. Epigenetic regulation of HIV-1 latency by cytosine methyla- tion. PLoS Pathog 5, e1000495.
119. Kerr, J. S., Galloway, S., Lagrutta, A., Armstrong, M., Miller, T., Richon, V. M. & Andrews, P. A. (2010). Nonclinical safety assessment of the histone deacetylase inhibitor Vorinostat. Int J Toxicol 29, 3-19.
120. Kornfeld, H., Cruikshank, W. W., Pyle, S. W., Berman, J. S. & Center, D. M. (1988). Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335, 445-448.
121. Kraase, M., Sloan, R., Klein, D., Logan, N., McMonagle, L., Biek, R., Willett, B. J. & Hosie, M. J. (2010). Feline immunodeficiency virus env gene evolution in experimentally infected cats. Vet Immunol Immunopathol 134, 96-106.
122. Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R. & Pomerantz, R. J. (2001). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98, 3006-3015.
123. Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V. (2008). T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134, 577-586.
124. Kwara, A., Delong, A., Rezk, N., Hogan, J., Burtwell, H., Chapman, S., Moreira, C. C., Kurpewski, J., Ingersoll, J. (2008). Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin Infect Dis 46, 719-725.
125. Kwon, H. S., Brent, M. M., Getachew, R., Jayakumar, P., Chen, L. F., Schnolzer, M., McBurney, M. W., Marmorstein, R., Greene, W. C. & Ott, M. (2008). Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe 3, 158-167.
126. Lassen, K. G., Bailey, J. R. & Siliciano, R. F. (2004). Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4 + T cells in vivo. J Virol 78, 9105-9114.
127. Lassen, K. G., Ramyar, K. X., Bailey, J. R., Zhou, Y. & Siliciano, R. F. (2006). Nuclear retention of multiply spliced HIV-1 RNA in resting CD4 + T cells. PLoS Pathog 2, e68.
128. Launay, O., Tod, M., Tschope, I., Si-Mohamed, A., Belarbi, L., Charpentier, C., Goujard, C., Taburet, A. M., Lortholary, O. (2011). Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study. Antivir Ther 16, 843-852.
129. Le Douce, V., Herbein, G., Rohr, O. & Schwartz, C. (2010). Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 7, 32.
130. Levy, Y., Lacabaratz, C., Weiss, L., Viard, J. P., Goujard, C., Lelievre, J. D., Boue, F., Molina, J. M., Rouzioux, C. (2009).Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 119, 997-1007.
131. Levy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelievre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebocontrolled, multicenter study. Clin Infect Dis 55, 291-300.
132. Lewin, S. R., Evans, V. A., Elliott, J. H., Spire, B. & Chomont, N. Finding a cure for HIV: will it ever be achievable? J Int AIDS Soc 14, 4.
133. Li, Z., Guo, J., Wu, Y. & Zhou, Q. (2013). The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res 41, 277-287.
134. Lusic, M., Marcello, A., Cereseto, A. & Giacca, M. (2003). Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 22, 6550-6561.
135. Mansky, L. M. & Temin, H. M. (1995). Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69, 5087-5094.
136. Marcello, A. (2006). Latency: the hidden HIV-1 challenge. Retrovirology 3, 7.
137. Margolis, L. & Shattock, R. (2006). Selective transmission of CCR5- utilizing HIV-1: the 'gatekeeper' problem resolved? Nat Rev Microbiol 4, 312-317.
138. Marini, A., Harper, J. M. & Romerio, F. (2008). An in vitro system to model the establishment and reactivation of HIV-1 latency. J Immunol 181, 7713-7720.
139. Marsden, M. D. & Zack, J. A. (2009). Eradication of HIV: current challenges and new directions. J Antimicrob Chemother 63, 7-10.
140. Mbonye, U. & Karn, J. (2011). Control of HIV latency by epigenetic and non-epigenetic mechanisms. Curr HIV Res 9, 554-567.
141. McDonnel, S. J., Sparger, E. E., Luciw, P. A. & Murphy, B. G. (2012). Pharmacologic reactivation of latent feline immunodeficiency virus ex vivo in peripheral CD4+ T-lymphocytes. Virus Res 170, 174-179.
142. McMahon, D., Jones, J., Wiegand, A., Gange, S. J., Kearney, M., Palmer, S., McNulty, S., Metcalf, J. A., Acosta, E. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis 50, 912-919.
143. McNamara, L. A. & Collins, K. L. (2011). Hematopoietic stem/ precursor cells as HIV reservoirs. Curr Opin HIV AIDS 6, 43-48.
144. Middleton, T., Lim, H. B., Montgomery, D., Rockway, T., Tang, H., Cheng, X. H., Lu, L. J., Mo, H. M., Kohlbrenner, W. E. & Molla, A. (2004). Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. Antiviral Res 64, 35-45.
145. Mowat, A. M. & Viney, J. L. (1997). The anatomical basis of intestinal immunity. Immunol Rev 156, 145-166.
146. Murphy, B., Vapniarsky, N., Hillman, C., Castillo, D., McDonnel, S., Moore, P., Luciw, P. A. & Sparger, E. E. (2012). FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection. Retrovirology 9, 12.
147. Neal, T. F., Holland, H. K., Baum, C. M., Villinger, F., Ansari, A. A., Saral, R., Wingard, J. R. & Fleming, W. H. (1995). CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86, 1749-1756.
148. Nicholson, J. K. A., Cross, G. D., Callaway, C. S. & McDougal, J. S. (1986). In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol 137, 323-329.
149. North, T. W., Higgins, J., Deere, J. D., Hayes, T. L., Villalobos, A., Adamson, L., Shacklett, B. L., Schinazi, R. F. & Luciw, P. A. (2010). Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol 84, 2913-2922.
150. Novotney, C., English, R. V., Housman, J., Davidson, M. G., Nasisse, M. P., Jeng, C. R., Davis, W. C. & Tompkins, M. B. (1990). Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. AIDS 4, 1213-1218.
151. O'Brien, S. J. & Moore, J. P. (2000). The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 177, 99-111.
152. O'Doherty, U., Swiggard, W. J. & Malim, M. H. (2000). Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74, 10074-10080.
153. Ostrowski, M. A., Chun, T. W., Justement, S. J., Motola, I., Spinelli, M. A., Adelsberger, J., Ehler, L. A., Mizell, S. B., Hallahan, C. W. & Fauci, A. S. (1999). Both memory and CD45RA+/CD62L + naive CD4 + T cells are infected in human immunodeficiency virus type 1- infected individuals. J Virol 73, 6430-6435.
154. Oswald-Richter, K., Grill, S. M., Leelawong, M. & Unutmaz, D. (2004). HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. Eur J Immunol 34, 1705-1714.
155. Pace, M. J., Agosto, L., Graf, E. H. & O'Doherty, U. (2011). HIV reservoirs and latency models. Virology 411, 344-354.
156. Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M. & King, M. S. (2008). Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A 105, 3879-3884.
157. Palmer, S., Josefsson, L. & Coffin, J. M. (2011). HIV reservoirs and the possibility of a cure for HIV infection. J Intern Med 270, 550-560.
158. Parada, C. A. & Roeder, R. G. (1996). Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384, 375-378.
159. Pattanayak, V., Ramirez, C. L., Joung, J. K. & Liu, D. R. (2011). Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 8, 765-770.
160. Pedersen, N. C., Ho, E. W., Brown, M. L. & Yamamoto, J. K. (1987). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-793.
161. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R. & Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2, 751-760.
162. Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26, 808-816.
163. Perez-Martinez, D., Tanaka, T. & Rabbitts, T. H. (2010). Intracellular antibodies and cancer: new technologies offer therapeutic opportunities. Bioessays 32, 589-598.
164. Pierson, T., Hoffman, T. L., Blankson, J., Finzi, D., Chadwick, K., Margolick, J. B., Buck, C., Siliciano, J. D., Doms, R. W. & Siliciano, R. F. (2000). Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type J Virol 74, 7824-7833.
165. Pierson, T. C., Zhou, Y., Kieffer, T. L., Ruff, C. T., Buck, C. & Siliciano, R. F. (2002). Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol 76, 8518-8531.
166. Prins, J. M., Jurriaans, S., van Praag, R. M., Blaak, H., van Rij, R., Schellekens, P. T., ten Berge, I. J., Yong, S. L., Fox, C. H. (1999). Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. AIDS 13, 2405-2410.
167. Ramratnam, B., Mittler, J. E., Zhang, L., Boden, D., Hurley, A., Fang, Macken, C. A., Perelson, A. S., Markowitz, M. & Ho, D. D. (2000). The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 6, 82-85.
168. Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J. S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE 4, e6093.
169. Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, & Pomerantz, R. J. (2009). The challenge of finding a cure for HIV infection. Science 323, 1304-1307.
170. Roesch, F., Meziane, O., Kula, A., Nisole, S., Porrot, F., Anderson, I., Mammano, F., Fassati, A., Marcello, A. (2012). Hyperthermia stimulates HIV-1 replication. PLoS Pathog 8, e1002792.
171. Rossi, M. I., Medina, K. L., Garrett, K., Kolar, G., Comp, P. C., Shultz, L. D., Capra, J. D., Wilson, P., Schipul, A. Kincade, P. W (2001). Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. J Immunol 167, 3033-3042.
172. Ruff, C. T., Ray, S. C., Kwon, P., Zinn, R., Pendleton, A., Hutton, N., Ashworth, R., Gange, S., Quinn, T. C. (2002).Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J Virol 76, 9481-9492.
173. Rullas, J., Bermejo, M., Garcia-Pérez, J., Beltán, M., González, N., Hezareh, M., Brown, S. J. & Alcami, J. (2004). Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. Antivir Ther 9, 545-554.
174. Sahu, G. K., Lee, K., Ji, J. X., Braciale, V., Baron, S. & Cloyd, M. W. A novel in vitro system to generate and study latently HIV- infected long-lived normal CD4+ T-lymphocytes. Virology 355, 127-137.
175. Sahu, G. K., Paar, D., Frost, S. D. W., Smith, M. M., Weaver, S. & Cloyd, M. W. (2009). Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. J Med Virol 81, 9-15.
176. Saleh, S., Solomon, A., Wightman, F., Xhilaga, M., Cameron, P. U. & Lewin, S. R. (2007). CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 110, 4161-4164.
177. Saleh, S., Wightman, F., Ramanayake, S., Alexander, M., Kumar, N., Khoury, G., Pereira, C., Purcell, D., Cameron, P. U. & Lewin, S. R. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4 + T cells. Retrovirology 8, 80.
178. Schnittman, S. M., Psallidopoulos, M. C., Lane, H. C., Thompson, L., Baseler, M., Massari, F., Fox, C. H., Salzman, N. P. & Fauci, A. S. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245, 305-308.
179. Schröder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R. & Bushman, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
180. Scripture-Adams, D. D., Brooks, D. G., Korin, Y. D. & Zack, J. A. (2002). Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol 76, 13077-13082.
181. Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, C., Zhang, H., Margolick, J. B., Blankson, J. N. & Siliciano, R. F. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491-501.
182. Shen, A. D., Zink, M. C., Mankowski, J. L., Chadwick, K., Margolick, J. B., Carruth, L. M., Li, M., Clements, J. E. & Siliciano, R. F. (2003). Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemes- trina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. J Virol 77, 4938-4949.
183. Shimojima, M., Miyazawa, T., Ikeda, Y., McMonagle, E. L., Haining, Akashi, H., Takeuchi, Y., Hosie, M. J. & Willett, B. J. (2004). Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303, 1192-1195.
184. Siliciano, R. F. & Greene, W. C. (2011). HIV Latency. Cold Spring Harbor Perspectives in Medicine 1.
185. Siliciano, J. D. & Siliciano, R. F. (2010). Biomarkers of HIV replication. Curr Opin HIV AIDS 5, 491-497.
186. Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J. & Siliciano, R. F. (2003). Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9, 727-728.
187. Sloan, R. D. & Wainberg, M. A. (2011). The role of unintegrated DNA in HIV infection. Retrovirology 8, 52.
188. + bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 149, 689-697.
189. Stevenson, M., Stanwick, T. L., Dempsey, M. P. & Lamonica, C. A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 9, 1551-1560.
190. Svarovskaia, E. S., Barr, R., Zhang, X. C., Pais, G. C. G., Marchand, C., Pommier, Y., Burke, T. R., Jr & Pathak, V. K. (2004). Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long- terminal-repeat-circle junctions. J Virol 78, 3210-3222.
191. Swan, C. H., Buhler, B., Tschan, M. P., Barbas, C. F. & Torbett, B. E. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Ther 13, 1480-1492.
192. Tobin, N. H., Learn, G. H., Holte, S. E., Wang, Y., Melvin, A. J., McKernan, J. L., Pawluk, D. M., Mohan, K. M., Lewis, P. F. (2005). Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol 79, 9625-9634.
193. Tompkins, M. B. & Tompkins, W. A. (2008). Lentivirus-induced immune dysregulation. Vet Immunol Immunopathol 123, 45-55.
194. Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A. & Manz, M. G. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104-107.
195. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H. (2006). Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12, 1198-1202.
196. Tyagi, M., Pearson, R. J. & Karn, J. (2010). Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 84, 6425-6437.
197. Tzachanis, D., Lafuente, E. M., Li, L. & Boussiotis, V. A. (2004). Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma 45, 1959-1967.
198. Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D. & Holmes, M. C. (2005). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646-651.
199. Van Duyne, R., Pedati, C., Guendel, I., Carpio, L., Kehn-Hall, K., Saifuddin, M. & Kashanchi, F. (2009). The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology 6, 76.
200. van Grevenynghe, J., Procopio, F. A., He, Z., Chomont, N., Riou, C., Zhang, Y., Gimmig, S., Boucher, G., Wilkinson, P. Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection. Nat Med 14, 266-274.
201. van Leeuwen, E. M. M., Sprent, J. & Surh, C. D. (2009). Generation and maintenance of memory CD4+ T cells. Curr Opin Immunol 21, 167-172.
202. Van Lint, C., Emiliani, S., Ott, M. & Verdin, E. (1996). Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15, 1112-1120.
203. Vatakis, D. N., Bristol, G., Wilkinson, T. A., Chow, S. A. & Zack, J. A. Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. J Virol 81, 3574-3582.
204. + T cells. J Virol 83, 6222-6233.
205. Vatakis, D. N., Nixon, C. C. & Zack, J. A. (2010). Quiescent T cells and HIV: an unresolved relationship. Immunol Res 48, 110-121.
206. Verdin, E., Paras, P., Jr & Van Lint, C. (1993). Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12, 3249-3259.
207. Volberding, P. A. & Deeks, S. G. (2010). Antiretroviral therapy and management of HIV infection. Lancet 376, 49-62.
208. Wang, F. X., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M. (2005). IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 115, 128-137.
209. Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M., Swofford, R., Venkatesan, S., Farber, J.M. & Fauci, A. S. (1997). Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389, 981-985.
210. Wightman, F., Solomon, A., Khoury, G., Green, J. A., Gray, L., Gorry, P. R., Ho, Y. S., Saksena, N. K., Hoy, J. (2010). Both CD31+ and CD31? naive CD4+ T cells are persistent HIV type 1- infected reservoirs in individuals receiving antiretroviral therapy. J Infect Dis 202, 1738-1748.
211. Wightman, F., Ellenberg, P., Churchill, M. & Lewin, S. R. (2012). HDAC inhibitors in HIV. Immunol Cell Biol 90, 47-54.
212. Wilen, C. B., Wang, J., Tilton, J. C., Miller, J. C., Kim, K. A., Rebar, E. J., Sherrill-Mix, S. A., Patro, S. C., Secreto, A. J. (2011). Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases. PLoS Pathog 7, e1002020.
213. Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. & Clapham, P. R. (1997). Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 71, 6407-6415.
214. Williams, S. A. & Greene, W. C. (2007). Regulation of HIV-1 latency by T-cell activation. Cytokine 39, 63-74.
215. Williams, S. A., Kwon, H., Chen, L. F. & Greene, W. C. (2007). Sustained induction of NF-kB is required for efficient expression of latent human immunodeficiency virus type 1. J Virol 81, 6043-6056.
216. Wolschendorf, F., Duverger, A., Jones, J., Wagner, F. H., Huff, J., Benjamin, W. H., Saag, M. S., Niederweis, M. & Kutsch, O. (2010). Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction. J Virol 84, 8712-8720.
217. Wu, Y. T. & Yoder, A. (2009). Chemokine coreceptor signaling in HIV- 1 infection and pathogenesis. PLoS Pathog 5, e1000520.
218. Wu, L. J., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W. (1997). CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185, 1681-1692.
219. Xing, S., Bullen, C. K., Shroff, N. S., Shan, L., Yang, H. C., Manucci, J. L., Bhat, S., Zhang, H., Margolick, J. B. (2011). Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J Virol 85, 6060-6064.
220. Xing, S. F., Bhat, S., Shroff, N. S., Zhang, H., Lopez, J. A., Margolick, J. B., Liu, J. O. & Siliciano, R. F. (2012). Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J Antimicrob Chemother 67, 398-403.
221. Yamamoto, J. K., Sparger, E., Ho, E. W., Andersen, P. R., O'Connor, T. P., Mandell, C. P., Lowenstine, L., Munn, R. & Pedersen, N. C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res 49, 1246-1258.
222. Yamamoto, J. K., Hansen, H., Ho, E. W., Morishita, T. Y., Okuda, T., Sawa, T. R., Nakamura, R. M. & Pedersen, N. C. (1989). Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 194, 213-220.
223. Yang, H. C. (2011). Primary cell models of HIV latency. Curr Opin HIV AIDS 6, 62-67.
224. Yang, H. C., Xing, S. F., Shan, L., O'Connell, K., Dinoso, J., Shen, A. D., Zhou, Y., Shrum, C. K., Han, Y. F. (2009). Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 119, 3473-3486.
225. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A. & Mayo, M. W. (2004). Modulation of NF-kB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23, 2369-2380.
226. Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch, R. J. & Margolis, M. (2004). Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18, 1101-1108.
227. Yoder, A., Yu, D. Y., Dong, L., Iyer, S. R., Xu, X. H., Kelly, J., Liu, J., Wang, W. F., Vorster, P. J. (2008). HIV envelope- CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 134, 782-792.
228. Yuan, J., Wang, J., Crain, K., Fearns, C., Kim, K. A., Hua, K. L., Gregory, P. D., Holmes, M. C. & Torbett, B. E. (2012). Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4+ T cell resistance and enrichment. Mol Ther 20, 849-859.
229. Yukl, S. A., Shergill, A. K., McQuaid, K., Gianella, S., Lampiris, H., Hare, C. B., Pandori, M., Sinclair, E., Günthard, H. F. Effect of Raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 24, 2451-2460.
230. Yusuf, I. & Fruman, D. A. (2003). Regulation of quiescence in lymphocytes. Trends Immunol 24, 380-386.
231. Zagury, D., Bernard, J., Leonard, R., Cheynier, R., Feldman, M., Sarin, P. S. & Gallo, R. C. (1986). Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 231, 850-853.
232. Zhou, Y., Zhang, H., Siliciano, J. D. & Siliciano, R. F. (2005). Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J Virol 79, 2199-2210.
233. Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A. & Ho, D. D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261, 1179-1181.
234. Zhu, J., Gaiha, G. D., John, S. P., Pertel, T., Chin, C. R., Gao, G., Qu, H., Walker, B. D., Elledge, S. J. & Brass, A. L. (2012). Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep 2, 807-816.